Health Care: Drugs

Ligand Pharmaceuticals Inc (LGND: NASDAQ)

$134.89 -1.18 | -0.87%
07/28/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 71.91M 64.54M 48.97M 31.39M
Cost of Sales 5.81M 2.56M 2.65M 874.00K
Gross Operating Profit 66.11M 61.98M 46.32M 30.51M
Selling, General, and Administrative Expenses 25.40M 22.57M 18.54M 16.11M
Research & Development 13.38M 12.12M 9.27M 10.79M
Operating Income before D & A (EBITDA) 27.33M 27.28M 18.50M 3.62M
Depreciation & Amortization 12.90M 6.57M 3.08M 2.73M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 24.95M -4.55M -3.66M -1.13M
Special Income / Charges 0.00 0.00 -480.00K -315.00K
Total Income Before Interest Expenses (EBIT) 34.23M 16.16M 11.28M -560.00K
Interest Expense 11.80M 4.86M 2.08M 3.31M
Pre-Tax Income 22.43M 11.30M 9.21M -3.87M
Income Taxes -219.60M 410.00K 374.00K -1.19M
Minority Interest -2.38M -1.13M 0.00 0.00
Net Income From Continuing Operations 254.93M 10.89M 8.83M -2.67M
Net Income From Discontinued Operations 0.00 0.00 2.59M 2.15M
Net Income From Total Operations 254.93M 10.89M 11.42M -527.00K
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 257.31M 12.02M 11.42M -527.00K
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
254.93M 10.89M 9.31M -2.36M
Preferred Dividends
Net Income Available To Common 254.93M 10.89M 8.83M -2.67M
Basic EPS from Continuing Ops. 13.00 0.59 0.43 -0.13
Basic EPS from Discontinued Ops. 0.00 0.00 0.13 0.11
Basic EPS from Total Operations 13.00 0.59 0.56 -0.02
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 -0.01
Basic EPS, Total 13.00 0.59 0.56 -0.03
Basic Normalized Net Income/Share 13.00 0.59 0.45 -0.11
EPS fr Continuing Ops. 12.12 0.56 0.43 -0.13
EPS fr Discontinued Ops 0.00 0.00 0.12 0.11
EPS fr Total Ops. 12.12 0.56 0.55 -0.02
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.13
EPS, Total 12.12 0.56 0.55 0.11
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
12.12 0.56 0.45 -0.12
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with LGND

Latest LGND Headlines from TheStreet

More Financial News for LGND

Press Releases for LGND

See All Press Releases

Partner Headlines for LGND

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter